XML 22 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Marketable Securities
6 Months Ended
Jun. 30, 2017
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Marketable Securities
Available-for-sale marketable securities and cash and cash equivalents as of June 30, 2017 and December 31, 2016 consist of the following (in thousands):
 
June 30, 2017
 
Amortized Cost Value
 
Gross 
Unrealized 
Gains
 
Gross 
Unrealized 
Losses
 
Fair Value
Cash and cash equivalents:
 

 
 

 
 

 
 

Cash
$
98,201

 
$

 
$

 
$
98,201

Money market funds
30,573

 

 

 
30,573

Domestic corporate debt securities
6,336

 

 

 
6,336

Total
$
135,110

 
$

 
$

 
$
135,110

 
 
 
 
 
 
 
 
Marketable securities:
 

 
 

 
 

 
 

Domestic corporate debt securities
$
34,918

 
$

 
$
(9
)
 
$
34,909

Domestic corporate commercial paper
44,685

 
12

 

 
44,697

Total
$
79,603

 
$
12

 
$
(9
)
 
$
79,606

 
 
December 31, 2016
 
Amortized Cost Value
 
Gross 
Unrealized 
Gains
 
Gross 
Unrealized 
Losses
 
Fair Value
Cash and cash equivalents:
 

 
 

 
 

 
 

Cash
$
77,443

 
$

 
$

 
$
77,443

Money market funds
173,631

 

 

 
173,631

Domestic corporate commercial paper
5,487

 

 

 
5,487

Domestic corporate debt securities
2,006

 

 

 
2,006

Total
$
258,567

 
$

 
$

 
$
258,567

 
 
 
 
 
 
 
 
Marketable securities:
 

 
 

 
 

 
 

Domestic corporate debt securities
$
19,317

 
$

 
$
(2
)
 
$
19,315

Domestic corporate commercial paper
31,852

 
78

 

 
31,930

Asset-backed securities
22,639

 

 
(4
)
 
22,635

Total
$
73,808

 
$
78

 
$
(6
)
 
$
73,880


There were no debt securities that had been in an unrealized loss position for more than 12 months as of June 30, 2017 or December 31, 2016. There were 15 debt securities in an unrealized loss position for less than 12 months at June 30, 2017 and there were 13 debt securities that had been in an unrealized loss position for less than 12 months at December 31, 2016. The aggregate unrealized loss on these securities as of June 30, 2017 and December 31, 2016 was approximately $9 thousand and $6 thousand, respectively, and the fair value was $33.7 million and $35.7 million, respectively. The Company considered the decrease in market value for these securities to be primarily attributable to current economic conditions. As it was not more likely than not that the Company would be required to sell these securities before the recovery of their amortized cost basis, which may be at maturity, the Company did not consider these investments to be other-than-temporarily impaired as of June 30, 2017.
As of June 30, 2017, marketable securities consisted of investments that mature within one year.